No Picture
News

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune DiseasesSeries A Investors Include Vida Ventures, Westlake Village BioPartners and Gilead SciencesDomin… […]

No Picture
News

AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences

– AN2’s Series A focused on advancing novel treatments for infectious diseases of global significance.- AN2 grants license to Brii Biosciences for study of the lead antibacterial program in greater China.

MENLO PARK, Calif., Nov. 21, 2019 /PRNewswi… […]

No Picture
News

CODA Biotherapeutics Announces Series A Extension, Bringing Total Round to $34 Million

– Proceeds will advance company’s chemogenetic gene therapy platform toward the clinic with an initial focus on chronic neuropathic pain and focal epilepsy –

SOUTH SAN FRANCISCO, Calif., Nov. 5, 2019 /PRNewswire/ — CODA Biotherapeutics, Inc., a prec… […]

No Picture
News

Molecular Assemblies Announces $12.2 M Series A Financing to Advance Enzymatic DNA Synthesis for Life Sciences and Data Storage

SAN DIEGO, Oct. 1, 2019 /PRNewswire/ — Molecular Assemblies, Inc., today announced that it has raised a $12.2 million Series A financing led by iSelect Fund and joined by existing investors, Agilent Technologies, Alexandria Venture Investments, and… […]

No Picture
News

GTCR and Golden Gate Capital Announce Recapitalization of Cole-Parmer Instrument Company

CHICAGO and SAN FRANCISCO and VERNON HILLS, Ill., Sept. 26, 2019 /PRNewswire/ — GTCR and Golden Gate Capital announced today that they have signed a definitive agreement to recapitalize Cole-Parmer Instrument Company (“Cole-Parmer”, or the “Company… […]

No Picture
News

Healthcare Technology Startup InsightRX Raises $10 Million to Enable Precision Dosing at Point of Care

Led by HealthX Ventures, Series A Funding Round Will Accelerate the Adoption of Precision Dosing within the Healthcare Industry

SAN FRANCISCO, Sept. 20, 2019 /PRNewswire/ — InsightRX, a pioneer in precision medicine, announced today the closing of i… […]